INFLUENCE OF ROUTE OF ADMINISTRATION ON PHYSIOLOGICAL AVAILABILITY OF LEVODOPA IN DOGS

被引：24

作者：

COTLER, S ^{[1
]}

HOLAZO, A ^{[1
]}

BOXENBAUM, HG ^{[1
]}

KAPLAN, SA ^{[1
]}

机构：

[1] HOFFMANN LA ROCHE INC,DEPT BIOCHEM & DRUG METAB,NUTLEY,NJ 07110

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1976年 / 65卷 / 06期

关键词：

D O I：

10.1002/jps.2600650607

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：822 / 827

页数：6

相关论文

共 29 条

[1] BARBEAU A, 1971, CLIN PHARMACOL THER, V12, P353
[2] INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE
BARTHOLINI, G
BURKARD, WP
PLETSCHER, A
BATES, HM
[J]. NATURE, 1967, 215 (5103) : 852 - +
[3] ABSORPTION AND METABOLISM OF A STANDARD ORAL DOSE OF LEVODOPA IN PATIENTS WITH PARKINSONISM
BERGMANN, S
CURZON, G
FRIEDEL, J
GODWINAU.RB
MARSDEN, CD
PARKES, JD
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (05) : 417 - 424
[4] METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE
BIANCHINE, JR
CALIMLIM, LR
MORGAN, JP
DUJUVNE, CA
LASAGNA, L
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 126 - +
[5] MODERN TREATMENT OF PARKINSONISM
BIRKMAYER, W
NEUMAYER, E
[J]. ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 257 - +
[6] L-DOPA LEVEL IN PLASMA, PRIMARY CONDITION FOR KINETIC EFFECT
BIRKMAYER, W
DANIELCYK, W
NEUMAYER, E
RIEDERER, P
[J]. JOURNAL OF NEURAL TRANSMISSION, 1973, 34 (02) : 133 - 143
[7] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
BOXENBAU.HG
RIEGELMA.S
ELASHOFF, RM
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
[8] BOYES RN, 1970, J PHARMACOL EXP THER, V174, P1
[9] LEVODOPA - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USES WITH PARTICULAR REFERENCE TO PARKINSONISM
BROGDON, RN
[J]. DRUGS, 1971, 2 (04) : 262 - +
[10] CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11